We encourage patients to download the NHS App, so that you can manage your healthcare. The App will give you the ability to view results, letters, order medication etc without having to call the practice. Hospitals are now making their appointments visible on the App and our national screening programmes, such as cervical cytology, are sending normal results through to the patient via this route.

Please see the NHS App page.

We now have a new Facebook group. Follow here for all the latest news: https://www.facebook.com/people/Glenside-Country-Practice/61581196102865/

Dear secondary care colleagues. Firstly, thanks for your ongoing care of our mutual patients in busy and challenging times. We appreciate your support as our patients do.

This communication has been developed in response to concerns raised to Lincolnshire LMC by GP practices about requests from Secondary care for practices to prescribe Tirzepatide (Mounjaro) for patients who have been seen in a secondary care setting.

From 23rd June 2025, in Lincolnshire, Tirzepatide can only be prescribed by clinicians providing the PCN Interim Primary Care Tier 3 Weight Management Service.

The patient cohort eligible for this was just 393 across Lincolnshire and required them to have a BMI >40 and four of the five following conditions:

·       Type 2 diabetes mellitus

·       Hypertension

·       Ischaemic Heart Disease

·       Obstructive sleep apnoea

·       Dyslipidaemia

Those eligible are identified by their PCN and invited for the programme.

Further information on the local programme is available here:

Lincolnshire PCN interim weight management service

Therefore, while noting the popularity of Tirzepatide (Mounjaro) amongst patients, Lincolnshire GP practices are not commissioned or permitted to prescribe and monitor this medication.

As such, while acknowledging that you may think a patient may benefit from Tirzepatide, we are not able to prescribe this in general practice unless they meet the above criteria and can be accepted onto the PCN service.

Please refrain from requesting we prescribe this in clinic letters you send us and please avoid asking patients to contact us to request we prescribe Tirzepatide as this sets a patient expectation which can negatively impact their relationship with us when we then have to decline the request.

Dr Reid D Baker

Medical Director Lincolnshire LMC Ltd

On behalf of Lincolnshire General Practice.

• These medicines must not be used during pregnancy, when trying to conceive, or while breastfeeding.
• If you're taking Mounjaro and are overweight, oral contraceptives may be less effective. You should also use another form of contraception, like the implant, coil, or condoms.
• Never buy these medicines from social media, beauty salons, or any other unregulated sources.
• You must report any side effects or counterfeit products via the MHRA’s Yellow Card scheme.

The prescribing of gluten-free foods in Lincolnshire is to cease from 1st August 2025.

NHS Lincolnshire Integrated Care Board (ICB) has taken the decision to stop prescribing gluten free products with effect from 1st August 2025. This is not a decision that the practice has made locally. 

More information can be found via this link: Gluten Free prescription changes - Lincolnshire ICB

You can also access further information about managing Coeliac Disease by visiting: www.nhs.uk/conditions/coeliac-disease

Coeliac UK Website at www.coeliac.org.uk  for further advice.

For enquiries, please contact Lincolnshire Integrated Care Board

Bridge House

The Point

Lions Way 

Sleaford

NG34 8GG

Mindfulness for Adolescents and Carers

• Young people aged between 15-18.
• Currently experiencing depression, low mood, or anxiety with low mood.
• Previously had help but still struggling.
• Willingness to participate in a new 8-week skills-based mindfulness group.

Participants will get a £60 thank you payment.

If you are interesting in joining, find out more information.